| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |